{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:48:21Z","timestamp":1791863301031,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"47","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["977\/21"],"award-info":[{"award-number":["977\/21"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ariane De Rothschild Women's Scholarship"},{"name":"Neubauer Doctoral Fellowships"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,12,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Numerous cellular pathways are known to cause resistance in cancer cells. The unfolded protein response (UPR), a signaling pathway activated during proteostasis stress in the endoplasmic reticulum (ER), is an adaptive process to increase cancer cell fitness. However, the molecular mechanism between ER stress, UPR activation, and chemoresistance is insufficiently understood. Here, we report that ER stress induction and UPR activation are necessary for chemoresistance to cisplatin and doxorubicin. Mild ER stress is a sufficient precondition for cancer cells to evade cisplatin- and doxorubicin-associated cell death. Mechanistically, ER stress induction results in the redistribution of PDIA4 from the ER to the cytosol, facilitated by the c-tail-anchored proteins DNAJB12 and DNAJB14 and the cytosolic HSC70-cochaperone SGTA. In the cytosol, PDIA4 forms an inhibitory interaction with caspase-3 and wt-p53, leading to their attenuation and increased cancer cell proliferation. Furthermore, we show that PDIA4 must originate from the ER to inhibit caspase-3 and wt-p53 in the cytosol. Silencing PDIA4, DNAJB12\/14, or SGTA rescues wt-p53 and caspase-3 activity. Finally, we found that in tumors isolated from colorectal cancer patients, PDIA4 and DNAJB12 are highly expressed compared to their healthy tissues; this expression is associated with the induction of the UPR. Our data show a novel non-genetic mechanism to inhibit apoptosis and suggest PDIA4, DNAJB12\/14, and SGTA as novel therapeutic targets to rescue apoptosis and inhibit proliferation in cancer cells.<\/jats:p>","DOI":"10.1038\/s41388-025-03606-7","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:31:14Z","timestamp":1761035474000},"page":"4565-4575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Non-genetic inactivation of caspase-3 and P53 increases cancer cell fitness by PDIA4 redistribution"],"prefix":"10.1038","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8234-317X","authenticated-orcid":false,"given":"Gal","family":"Twito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza Amterat","family":"Abu Abayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayelet","family":"Gilad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suma","family":"Biadsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Gavriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suad","family":"Sheikh Suliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarden","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Megged","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mor","family":"Tenenboim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Abu-Freha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3940-1824","authenticated-orcid":false,"given":"Aeid","family":"Igbaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"3606_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02145-1","volume":"23","author":"S Li","year":"2024","unstructured":"Li S, Lv J, Li Z, Zhang Q, Lu J, Huo X, et al. Overcoming multi-drug resistance in SCLC: a synergistic approach with venetoclax and hydroxychloroquine targeting the lncRNA LYPLAL1-DT\/BCL2\/BECN1 pathway. Mol Cancer. 2024;23:243.","journal-title":"Mol Cancer"},{"key":"3606_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1124\/pr.111.005637","volume":"64","author":"DW Shen","year":"2012","unstructured":"Shen DW, Pouliot LM, Hall MD, Gottesman MM. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 2012;64:706\u201321.","journal-title":"Pharmacol Rev"},{"key":"3606_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang N, Ma T, Yu B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct Target Ther. 2023;8:69.","journal-title":"Signal Transduct Target Ther"},{"key":"3606_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41568-023-00612-3","volume":"23","author":"A Sajid","year":"2023","unstructured":"Sajid A, Rahman H, Ambudkar SV. Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters. Nat Rev Cancer. 2023;23:762\u201379.","journal-title":"Nat Rev Cancer"},{"key":"3606_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/BF00623551","volume":"60","author":"B Rosenberg","year":"1973","unstructured":"Rosenberg B. Platinum coordination complexes in cancer chemotherapy. Naturwissenschaften. 1973;60:399\u2013406.","journal-title":"Naturwissenschaften"},{"key":"3606_CR6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1021\/acs.chemrestox.8b00170","volume":"31","author":"S Wang","year":"2018","unstructured":"Wang S, Scharadin TM, Zimmermann M, Malfatti MA, Turteltaub KW, de Vere White R, et al. Correlation of platinum cytotoxicity to drug-DNA adduct levels in a breast cancer cell line panel. Chem Res Toxicol. 2018;31:1293\u2013304.","journal-title":"Chem Res Toxicol"},{"key":"3606_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","volume":"57","author":"DA Gewirtz","year":"1999","unstructured":"Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharm. 1999;57:727\u201341.","journal-title":"Biochem Pharm"},{"key":"3606_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76210-6","volume":"14","author":"J Carron","year":"2024","unstructured":"Carron J, Coser LO, Lima CSP, Lourenco GJ. The impact of ERP29 on the progression of pharyngeal squamous cell carcinoma. Sci Rep. 2024;14:25681.","journal-title":"Sci Rep."},{"key":"3606_CR9","doi-asserted-by":"crossref","unstructured":"Xiang Y, Jia M, Gao Y, Yang F, Wang T, Dai R, et al. Cisplatin Disrupts Proteasome Bounce-Back Effect through Suppressing ZEB1\/Nfe2l1 in Cholangiocarcinoma. Front Biosci (Landmark Ed. 2024;29:106..","DOI":"10.31083\/j.fbl2903106"},{"key":"3606_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110413","volume":"27","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Fu M, Qi J, Xu Z, Wang Y, Wang Z, et al. Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer. iScience. 2024;27:110413.","journal-title":"iScience"},{"key":"3606_CR11","first-page":"3077","volume":"59","author":"KM Henkels","year":"1999","unstructured":"Henkels KM, Turchi JJ. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res. 1999;59:3077\u201383.","journal-title":"Cancer Res"},{"key":"3606_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2016.03.007","volume":"2","author":"H Urra","year":"2016","unstructured":"Urra H, Dufey E, Avril T, Chevet E, Hetz C. Endoplasmic Reticulum Stress and the Hallmarks of Cancer. Trends Cancer. 2016;2:252\u201362.","journal-title":"Trends Cancer"},{"key":"3606_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/febs.14359","volume":"286","author":"J Obacz","year":"2019","unstructured":"Obacz J, Avril T, Rubio-Patino C, Bossowski JP, Igbaria A, Ricci JE, et al. Regulation of tumor-stroma interactions by the unfolded protein response. FEBS J. 2019;286:279\u201396.","journal-title":"FEBS J"},{"key":"3606_CR14","first-page":"159","volume":"414","author":"A Papaioannou","year":"2018","unstructured":"Papaioannou A, Chevet E. Driving cancer tumorigenesis and metastasis through UPR signaling. Curr Top Microbiol Immunol. 2018;414:159\u201392.","journal-title":"Curr Top Microbiol Immunol"},{"key":"3606_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.72","volume":"6","author":"T Avril","year":"2017","unstructured":"Avril T, Vauleon E, Chevet E. Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers. Oncogenesis. 2017;6:e373.","journal-title":"Oncogenesis"},{"key":"3606_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/CCO.0000000000000339","volume":"29","author":"A Galmiche","year":"2017","unstructured":"Galmiche A, Sauzay C, Chevet E, Pluquet O. Role of the unfolded protein response in tumor cell characteristics and cancer outcome. Curr Opin Oncol. 2017;29:41\u20137.","journal-title":"Curr Opin Oncol"},{"key":"3606_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s11658-025-00735-5","volume":"30","author":"JH Lee","year":"2025","unstructured":"Lee JH, Seo SH, Shim J, Kim YN, Yoon K. Narciclasine enhances cisplatin-induced apoptotic cell death by inducing unfolded protein response-mediated regulation of NOXA and MCL1. Cell Mol Biol Lett. 2025;30:59.","journal-title":"Cell Mol Biol Lett"},{"key":"3606_CR18","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s13402-024-01010-z","volume":"47","author":"S Lv","year":"2024","unstructured":"Lv S, Zhang L, Wu M, Zhu S, Wang Y, Liu L, et al. IRE1alpha inhibitor reduces cisplatin resistance in ovarian cancer by modulating IRE1alpha\/XBP1 pathway. Cell Oncol (Dordr). 2024;47:2233\u201346.","journal-title":"Cell Oncol (Dordr)"},{"key":"3606_CR19","doi-asserted-by":"publisher","first-page":"22382","DOI":"10.1038\/s41598-024-70561-w","volume":"14","author":"J Li","year":"2024","unstructured":"Li J, Rouse SL, Matthews IR, Park Y, Eltawil Y, Sherr EH. et al. Modulating the unfolded protein response with ISRIB mitigatescisplatin ototoxicity. Sci Rep. 2024;14:22382.","journal-title":"Sci Rep"},{"key":"3606_CR20","doi-asserted-by":"publisher","first-page":"51854","DOI":"10.18632\/oncotarget.10126","volume":"7","author":"A Fujimoto","year":"2016","unstructured":"Fujimoto A, Kawana K, Taguchi A, Adachi K, Sato M, Nakamura H, et al. Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosis. Oncotarget. 2016;7:51854\u201364.","journal-title":"Oncotarget"},{"key":"3606_CR21","doi-asserted-by":"publisher","first-page":"e73267","DOI":"10.1371\/journal.pone.0073267","volume":"8","author":"LM Epple","year":"2013","unstructured":"Epple LM, Dodd RD, Merz AL, Dechkovskaia AM, Herring M, Winston BA, et al. Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells. PLoS One. 2013;8:e73267.","journal-title":"PLoS One"},{"key":"3606_CR22","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1158\/0008-5472.CAN-06-4594","volume":"67","author":"Y Fu","year":"2007","unstructured":"Fu Y, Li J, Lee AS. GRP78\/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 2007;67:3734\u201340.","journal-title":"Cancer Res"},{"key":"3606_CR23","doi-asserted-by":"publisher","first-page":"11291","DOI":"10.1073\/pnas.1904516116","volume":"116","author":"A Igbaria","year":"2019","unstructured":"Igbaria A, Merksamer PI, Trusina A, Tilahun F, Johnson JR, Brandman O, et al. Chaperone-mediated reflux of secretory proteins to the cytosol during endoplasmic reticulum stress. Proc Natl Acad Sci USA. 2019;116:11291\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3606_CR24","doi-asserted-by":"publisher","unstructured":"Dabsan S, Zur G, Abu-Freha N, Sofer S, Grossman-Haham I, Gilad A, et al. Cytosolic and endoplasmic reticulum chaperonesinhibit wt-p53 to increase cancer cells\u2019 survival by refluxing ER-proteins to the cytosol. Elife. 2025;14. https:\/\/doi.org\/10.7554\/eLife.102658.","DOI":"10.7554\/eLife.102658"},{"key":"3606_CR25","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/febs.17201","volume":"292","author":"S Dabsan","year":"2025","unstructured":"Dabsan S, Twito G, Biadsy S, Igbaria A. Less is better: various means to reduce protein load in the endoplasmic reticulum. FEBS J. 2025;292:976\u201389.","journal-title":"FEBS J"},{"key":"3606_CR26","doi-asserted-by":"publisher","first-page":"e51412.","DOI":"10.15252\/embr.202051412","volume":"22","author":"D Sicari","year":"2021","unstructured":"Sicari D, Centonze FG, Pineau R, Le Reste PJ, Negroni L, Chat S. et al. Reflux of Endoplasmic Reticulum proteins to the cytosol inactivates tumor suppressors. EMBO Rep. 2021;22:e51412.","journal-title":"EMBO Rep"},{"key":"3606_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/tra.12729","volume":"21","author":"P Lajoie","year":"2020","unstructured":"Lajoie P, Snapp EL. Size-dependent secretory protein reflux into the cytosol in association with acute endoplasmic reticulum stress. Traffic. 2020;21:419\u201329.","journal-title":"Traffic"},{"key":"3606_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00018-025-05803-9","volume":"82","author":"FAA Abayed","year":"2025","unstructured":"Abayed FAA, Abu Madegam L, Gilad A, Twito G, Suliman SS, Biadsy S, et al. Spatial protein redistribution: wandering but not lost. Cell Mol Life Sci. 2025;82:315.","journal-title":"Cell Mol Life Sci"},{"key":"3606_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2023.130502","volume":"1868","author":"ADD Purificacao","year":"2024","unstructured":"Purificacao ADD, Debbas V, Tanaka LY, Gabriel GVM, Wosniak Junior J, De Bessa TC, et al. DNAJB12 and DNJB14 are non-redundant Hsp40 redox chaperones involved in endoplasmic reticulum protein reflux. Biochim Biophys Acta Gen Subj. 2024;1868:130502.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"3606_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15694-y","volume":"11","author":"E Dufey","year":"2020","unstructured":"Dufey E, Bravo-San Pedro JM, Eggers C, Gonzalez-Quiroz M, Urra H, Sagredo AI, et al. Genotoxic stress triggers the activation of IRE1alpha-dependent RNA decay to modulate the DNA damage response. Nat Commun. 2020;11:2401.","journal-title":"Nat Commun"},{"key":"3606_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.tcb.2020.09.002","volume":"30","author":"M Gonzalez-Quiroz","year":"2020","unstructured":"Gonzalez-Quiroz M, Blondel A, Sagredo A, Hetz C, Chevet E, Pedeux R. When Endoplasmic Reticulum Proteostasis Meets the DNA Damage Response. Trends Cell Biol. 2020;30:881\u201391.","journal-title":"Trends Cell Biol"},{"key":"3606_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5483\/BMBRep.2020.53.2.108","volume":"53","author":"E Jung","year":"2020","unstructured":"Jung E, Koh D, Lim Y, Shin SY, Lee YH. Overcoming multidrug resistance by activating unfolded protein response of the endoplasmic reticulum in cisplatin-resistant A2780\/CisR ovarian cancer cells. BMB Rep. 2020;53:88\u201393.","journal-title":"BMB Rep."},{"key":"3606_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep33353","volume":"6","author":"D Jiang","year":"2016","unstructured":"Jiang D, Lynch C, Medeiros BC, Liedtke M, Bam R, Tam AB, et al. Identification of Doxorubicin as an Inhibitor of the IRE1alpha-XBP1 Axis of the Unfolded Protein Response. Sci Rep. 2016;6:33353.","journal-title":"Sci Rep."},{"key":"3606_CR34","first-page":"347","volume":"31","author":"X Zhao","year":"2016","unstructured":"Zhao X, Yang Y, Yao F, Xiao B, Cheng Y, Feng C, et al. Unfolded protein response promotes doxorubicin-induced nonsmall cell lung cancer cells apoptosis via the mTOR pathway inhibition. Cancer Biother Radiopharm. 2016;31:347\u201351.","journal-title":"Cancer Biother Radiopharm"},{"key":"3606_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/febs.15107","volume":"287","author":"D Sicari","year":"2020","unstructured":"Sicari D, Delaunay-Moisan A, Combettes L, Chevet E, Igbaria A. A guide to assessing endoplasmic reticulum homeostasis and stress in mammalian systems. FEBS J. 2020;287:27\u201342.","journal-title":"FEBS J"},{"key":"3606_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-2-243","volume":"2","author":"P Holden","year":"2009","unstructured":"Holden P, Horton WA. Crude subcellular fractionation of cultured mammalian cell lines. BMC Res Notes. 2009;2:243.","journal-title":"BMC Res Notes"},{"key":"3606_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1083\/jcb.200903014","volume":"186","author":"J Hollien","year":"2009","unstructured":"Hollien J, Lin JH, Li H, Stevens N, Walter P, Weissman JS. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell Biol. 2009;186:323\u201331.","journal-title":"J Cell Biol"},{"key":"3606_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1089\/ars.2024.0561","volume":"41","author":"AS Pierre","year":"2024","unstructured":"Pierre AS, Gavriel N, Guilbard M, Ogier-Denis E, Chevet E, Delom F. et al. Modulation of Protein Disulfide Isomerase Functions by Localization: The Example of the Anterior Gradient Family. Antioxid Redox Signal. 2024;41:675\u201392.","journal-title":"Antioxid Redox Signal"},{"key":"3606_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215604","volume":"534","author":"ME Law","year":"2022","unstructured":"Law ME, Yaaghubi E, Ghilardi AF, Davis BJ, Ferreira RB, Koh J, et al. Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death. Cancer Lett. 2022;534:215604.","journal-title":"Cancer Lett"},{"key":"3606_CR40","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1038\/onc.2017.156","volume":"36","author":"TF Kuo","year":"2017","unstructured":"Kuo TF, Chen TY, Jiang ST, Chen KW, Chiang YM, Hsu YJ, et al. Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway. Oncogene. 2017;36:5484\u201396.","journal-title":"Oncogene"},{"key":"3606_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1016-8478(23)07337-5","volume":"24","author":"KS Na","year":"2007","unstructured":"Na KS, Park BC, Jang M, Cho S, Lee DH, Kang S, et al. Protein disulfide isomerase is cleaved by caspase-3 and -7 during apoptosis. Mol Cells. 2007;24:261\u20137.","journal-title":"Mol Cells"},{"key":"3606_CR42","doi-asserted-by":"publisher","unstructured":"Liu Y, He H, Zou Y, Feng J, Liu H, Gao P, et al. High expression of PDIA4 contributes to poor prognosis in glioma. Biotechnol Appl Biochem. 2025. https:\/\/doi.org\/10.1002\/bab.70042.","DOI":"10.1002\/bab.70042"},{"key":"3606_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/OTT.S287931","volume":"14","author":"H Li","year":"2021","unstructured":"Li H, Liu Q, Xiao K, He Z, Wu C, Sun J, et al. PDIA4 correlates with poor prognosis and is a potential biomarker in glioma. Onco Targets Ther. 2021;14:125\u201338.","journal-title":"Onco Targets Ther"},{"key":"3606_CR44","doi-asserted-by":"publisher","unstructured":"Xing F, Song Z, Cheng Z. High expression of PDIA4 promotes malignant cell behavior and predicts reduced survival in cervical cancer. Oncol Rep. 2022;48. https:\/\/doi.org\/10.3892\/or.2022.8399.","DOI":"10.3892\/or.2022.8399"},{"key":"3606_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05719-x","volume":"14","author":"L Kang","year":"2023","unstructured":"Kang L, Wang D, Shen T, Liu X, Dai B, Zhou D, et al. PDIA4 confers resistance to ferroptosis via induction of ATF4\/SLC7A11 in renal cell carcinoma. Cell Death Dis. 2023;14:193.","journal-title":"Cell Death Dis"},{"key":"3606_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110569","volume":"38","author":"JC Smith","year":"2022","unstructured":"Smith JC, Sheltzer JM. Genome-wide identification and analysis of prognostic features in human cancers. Cell Rep. 2022;38:110569.","journal-title":"Cell Rep."},{"key":"3606_CR47","doi-asserted-by":"publisher","unstructured":"Smith JC, Sheltzer JM. Systematic identification of mutations and copy number alterations associated with cancer patient prognosis. Elife. 2018;7. https:\/\/doi.org\/10.7554\/eLife.39217.","DOI":"10.7554\/eLife.39217"}],"updated-by":[{"DOI":"10.1038\/s41388-025-03616-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03606-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03606-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03606-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:02:29Z","timestamp":1763420549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03606-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":47,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025,12,9]]}},"alternative-id":["3606"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03606-7","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In this article the title was incorrectly given as \u2018On-genetic inactivation of caspase-3 and P53 increases cancer cell fitness by PDIA4 redistribution\u2019 but should have been \u2018Non-genetic inactivation of caspase-3 and P53 increases cancer cell fitness by PDIA4 redistribution\u2019.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-025-03616-5","URL":"https:\/\/doi.org\/10.1038\/s41388-025-03616-5","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from all patients, and the study was approved by the ethics committee at Soroka University Medical Center (0367-23-SOR). Human samples used in this study were collected under Helsinki approval for biobank sample collection (approval number 0137-18). Approval date 12\/11\/2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}